RIGL
Rigel Pharmaceuticals Inc
Price:  
27.61 
USD
Volume:  
97,549.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL WACC - Weighted Average Cost of Capital

The WACC of Rigel Pharmaceuticals Inc (RIGL) is 7.9%.

The Cost of Equity of Rigel Pharmaceuticals Inc (RIGL) is 7.70%.
The Cost of Debt of Rigel Pharmaceuticals Inc (RIGL) is 13.70%.

Range Selected
Cost of equity 6.60% - 8.80% 7.70%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 11.80% - 15.60% 13.70%
WACC 6.8% - 9.1% 7.9%
WACC

RIGL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.6 0.7
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 8.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.12 0.12
Cost of debt 11.80% 15.60%
After-tax WACC 6.8% 9.1%
Selected WACC 7.9%